Summary
This narrative review examines the expanding use of transcatheter tricuspid interventions in Asia Pacific clinical practice over the past decade. The authors identify the absence of a standardised diagnostic algorithm for symptomatic tricuspid regurgitation as a significant barrier to equitable patient access to novel therapies, and highlight how anatomic diversity, disease prevalence patterns, socioeconomic factors, and health system structures present region-specific challenges to the management of right heart failure.
Regional applicability
This paper is primarily focused on Asia Pacific practice and does not directly address United Kingdom conditions. However, the identified gaps in standardised diagnostic algorithms and access frameworks may have relevance to UK cardiac intervention services seeking to harmonise tricuspid regurgitation screening and treatment protocols across different health systems and patient populations.
Key measures
Not specified; this is a qualitative review of transcatheter tricuspid intervention adoption, diagnostic approaches, and regional barriers to treatment access
Outcomes reported
The paper reviews the current status and clinical implementation of transcatheter tricuspid interventions across the Asia Pacific region, identifying gaps in standardised diagnostic algorithms and highlighting regional challenges in patient access to novel right heart therapies.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.